What are the best treatments for Polymyalgia Rheumatica?

The primary treatment for Polymyalgia Rheumatica consists of low-dose systemic corticosteroids, which typically provide rapid relief from muscle pain and stiffness. While these medications are highly effective, long-term management of Polymyalgia Rheumatica requires a personalized tapering strategy to minimize side effects and prevent disease relapse.

What are the first-line treatments for Polymyalgia Rheumatica?

The gold standard for treating Polymyalgia Rheumatica is the use of corticosteroids, such as prednisone (Deltasone, Rayos). Most patients experience significant improvement in symptoms within days of starting therapy. Because long-term steroid use carries risks like bone density loss and metabolic changes, physicians focus on a gradual taper to the lowest effective dose. In cases where patients are resistant to steroids or experience frequent flares, doctors may introduce steroid-sparing agents like methotrexate (Trexall) or interleukin-6 inhibitors like tocilizumab (Actemra).

What non-pharmacological therapies help manage symptoms?

Managing Polymyalgia Rheumatica involves more than just medication. A holistic approach includes:

• Physical Therapy: Gentle, low-impact exercise helps maintain joint mobility and prevents muscle atrophy.


• Occupational Therapy: Useful for patients experiencing severe stiffness, providing tools to assist with daily living tasks.


• Bone Health Monitoring: Since corticosteroids impact bone density, calcium and Vitamin D supplementation are often recommended.


• Balanced Nutrition: Anti-inflammatory diets can support overall wellness during the treatment of Polymyalgia Rheumatica.

Which specialists should be on my care team?

Because Polymyalgia Rheumatica is a systemic inflammatory condition, it requires a multidisciplinary care team. Your team should ideally include a rheumatologist to manage the inflammatory process, a primary care physician for overall health coordination, and potentially an endocrinologist if steroid side effects impact blood sugar or bone health. Within the DiseaseMaps.org community, 52 people with Polymyalgia Rheumatica have shared their experiences, highlighting the value of connecting with others who navigate these same specialist networks.

How does treatment effectiveness vary between patients?

Treatment response for Polymyalgia Rheumatica is highly individual. While most patients achieve remission within 1 to 2 years, approximately 50% of patients experience at least one relapse during the tapering process. Factors such as age, baseline inflammatory markers (like ESR and CRP), and co-existing conditions can influence how quickly an individual reaches remission.

Next steps

• Consult your rheumatologist to discuss a personalized steroid tapering schedule.


• Request a DEXA scan to monitor bone density if you are on long-term corticosteroid therapy.


• Join the Polymyalgia Rheumatica community on DiseaseMaps.org to share insights with others.


• Keep a symptom journal to track flares and triggers for your next clinical appointment.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment; always consult your personal physician regarding your specific health needs.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Polymyalgia Rheumatica.


• American College of Rheumatology: Guidelines for the Management of Polymyalgia Rheumatica.


• Orphanet: Rare Disease Database (Polymyalgia Rheumatica).


• PubMed/NCBI: Clinical trials regarding tocilizumab and steroid-sparing therapies.